Startups channel feed – Endpoints News

Startups channel feed

Backed by Big Pharma VCs, Palleon ramps up a new approach to immuno-oncology with a $48M startup round

8 years ago

Top scientists and BD execs craft Cullinan, a $150 million R&D portfolio shop focused on cancer

8 years ago

Genzyme vet David Meeker takes helm at stealthy KSQ with $76M and a new map for drug discovery

8 years ago

GSK spinout NeRRe splits the pipeline, creates its own spinout

8 years ago

Two young scientists bag $20M to perfect their CRISPR attack on disease-causing bacteria at upstart Eligo

8 years ago

Pfizer spins off drug orphans into a PhIII-ready startup backed by Bain to the tune of $103M

8 years ago

OrbiMed, RA Capital back a $26M raise for Realm’s two mid-stage drugs

8 years ago

With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII

8 years ago

Chris Garabedian's Xontogeny shepherds its first biotech through a $10M startup round

8 years ago

Tech maven Travis May takes the helm of Roivant's data mining startup

8 years ago

From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world

8 years ago

Atlas ramps up a new biotech player focused on neurology, with a $30M round to fund the work

8 years ago

Harvard biotech wiz Greg Verdine grabs a $55M A round to build a groundbreaking biotech

8 years ago

Cut loose from Biogen buyout option, Rodin preps for an early-stage shot at Alzheimer’s

8 years ago

Searching for a few great drugs, BridgeBio bags $135M to back a fresh slate of R&D bets

8 years ago

ProQR spins out a new RNA biotech focused on CNS diseases

8 years ago

Replimune adds a $55M round and some expert help as it pursues next-gen oncolytics R&D

8 years ago

Google helps boost Gritstone’s neoantigen R&D gamble to $195M as researchers prep for first human study

8 years ago

Big names, big companies back a cell therapy startup run by a high-profile regenerative med expert

8 years ago

The big revamp at GlaxoSmithKline R&D includes a new collaboration on AI

8 years ago

Orbimed partner in search of a cure for Parkinson’s launches new gene therapy player

8 years ago

SoftBank bets $1.1B on Roivant CEO Vivek Ramaswamy’s brash new biotech strategy

8 years ago

Amplyx grabs $67M to fund a pivotal drive to the FDA with an anti-fungal aimed at a lethal threat

8 years ago

Milestone Pharma preps a leap into PhIII cardio study with $55M round backed by Novo

8 years ago

First page Previous page 67 68 697071 72 73 Next page Last page